Related Experiment Video
Updated: Jun 21, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
BDNF and PDE4, but not the GRPR, regulate viability of human medulloblastoma cells
Anna Laura Schmidt1, Caroline Brunetto de Farias, Ana Lucia Abujamra
1Cancer Research Laboratory, University Hospital Research Center (CPE-HCPA), Federal University of Rio Grande do Sul, Rua Sarmento Leite, 2350, 90035-003, Porto Alegre, RS, Brazil.
Abstract:
Medulloblastoma is the most common brain tumor of childhood. Emerging molecular targets in medulloblastoma include neurotrophin and neuropeptide receptors. In the present study, we have examined the influence of brain-derived neurotrophic factor (BDNF)/TrkB receptor- and gastrin-releasing peptide receptor (GRPR)-mediated signaling on the viability of human medulloblastoma cells. The expression of TrkB and GRPR was confirmed by immunohistochemistry and mRNA for both BDNF and GRPR was detected by reverse transcriptase polymerase chain reaction in Daoy, D283, and ONS76 cells. Treatment with BDNF significantly inhibited the viability of Daoy and D283, but not ONS76 cells, measured with the MTT assay. Neither the GRPR agonists GRP and bombesin nor the GRPR antagonist RC-3095 affected cell viability. Because previous findings have indicated that the viability of glioma cells might be enhanced by GRP when combined with the cAMP phosphodiesterase-4 (PDE4) inhibitor rolipram, we also examined the effects of rolipram alone or combined with GRP on cell viability. Rolipram significantly reduced the viability of all three cell lines, and the inhibitory effect of rolipram in Daoy cells was not modified by cotreatment with GRP. The results suggest that BDNF/TrkB and PDE4, but not the GRPR, regulate the viability of medulloblastoma cells.
Insights
Brain-derived neurotrophic factor (BDNF) and phosphodiesterase-4 (PDE4) inhibitors impact medulloblastoma cell viability. Gastrin-releasing peptide receptor (GRPR) signaling does not influence these pediatric brain tumors.
Area of Science:
- Neuro-oncology
- Molecular biology
- Cellular signaling
Background:
- Medulloblastoma is the most common pediatric brain tumor.
- Neurotrophin and neuropeptide receptors are emerging molecular targets.
- Understanding signaling pathways is crucial for developing new therapies.
Purpose of the Study:
- To investigate the role of brain-derived neurotrophic factor (BDNF)/TrkB receptor and gastrin-releasing peptide receptor (GRPR) signaling in medulloblastoma cell viability.
- To explore the effects of BDNF, GRPR agonists/antagonists, and a PDE4 inhibitor on medulloblastoma cell lines.
Main Methods:
- Immunohistochemistry and reverse transcriptase polymerase chain reaction (RT-PCR) were used to confirm receptor and ligand expression.
- Cell viability was assessed using the MTT assay.
- Medulloblastoma cell lines (Daoy, D283, ONS76) were treated with BDNF, GRP, bombesin, RC-3095, and rolipram, alone or in combination.
Main Results:
- BDNF significantly inhibited the viability of Daoy and D283 medulloblastoma cells, but not ONS76 cells.
- GRPR agonists (GRP, bombesin) and antagonist (RC-3095) did not affect cell viability.
- Rolipram (a PDE4 inhibitor) significantly reduced the viability of all three cell lines, with no modification by GRP cotreatment.
Conclusions:
- BDNF/TrkB signaling pathway and phosphodiesterase-4 (PDE4) play a significant role in regulating medulloblastoma cell viability.
- The gastrin-releasing peptide receptor (GRPR) pathway does not appear to influence the viability of these medulloblastoma cells.
- These findings highlight potential therapeutic targets for medulloblastoma treatment.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules
Abnormal Proliferation

